MAXIMIZING ONCOLOGY EXPLORATION WITH BUILT-IN KRAS ASSAY PRODUCTS AND SERVICES AND RAS ASSAYS

within the speedily evolving area of oncology analysis, correct and effective mutation screening is vital for establishing targeted therapies. The KRAS providers System plays a pivotal part On this landscape by providing detailed alternatives for KRAS mutation profiling and Assessment. KRAS mutations, located in approximately ninety five% of RAS-as